๐ฐ Crispr News
Page 28 - Crispr News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Crispr. Real-time updates on events, politics, business and more.
June 9, 2022
The Human Genome Project was an ambitious initiative to sequence every piece of human DNA. The project drew together collaborators from research institutions around the world, including Whitehead Institute, and was finally completed in 2003.
June 8, 2022
Instead of deleting genes, epigenetic editing modulates their activity. A new paper tests if itโs able to undo a genetic effect of early alcohol exposure.
May 27, 2022
While plant scientists feel that the governmentโs move will help develop high-yield, disease-resistant crops, activists and policy experts have objected to the change being introduced through an office memorandum, which the public cannot raise objections against.
May 26, 2022
An effort by mad scientists to turn hamsters into more peaceful and docile creatures through gene editing went awry when the rodents ended up transforming into "hyper-aggressive [...]
May 17, 2022
Researchers have used CRISPR-Cas9 to knockout Avpr1a receptors in hamsters, eliminating vasopressins social behavior regulation.
May 11, 2022
A mutation in a gene involved in chromatin remodeling is associated with aggressive melanoma, suggest new data from preclinical research.
May 6, 2022
The world is going to need about 50% more food by 2050. Has the time come to roll out genetically modified crops that promise higher yields, are more resilient to climate change and reduce the carbon footprint of farming?
April 29, 2022
This application note dives into recent research from Boehringer Ingelheim that utilized Twist Bioscience’s silicon-based DNA synthesis platform to produce high-quality, customized oligos for CRISPR screens.
April 25, 2022
The Chinese scientist who claimed to have created the worldโs first gene-edited babies was quietly released from prison ...
April 20, 2022
Tiny capsule that delivers CRISPR gene therapy to the brain could be used to target glioblastoma tumours